#combination therapy — Tuesday, January 20, 2026 (1 items)
| 0 | ℹ |
CDK4/6 inhibition overcomes venetoclax resistance mechanisms with enhanced combination activity in acute myeloid leukemia.
(linkinghub.elsevier.com)
|
Cell Reports Medicine 2026-01-20 | #amr #leukemia #protein synthesis #combination therapy #crispr screening |